News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Marianne J. Davies, NP

Advertisement

Articles by Marianne J. Davies, NP

Marianne J. Davies, NP, Discusses the Peer Review Process at Yale Cancer Center

ByMarianne J. Davies, NP
July 10th 2014

Marianne J. Davies, NP, Yale Cancer Center, discusses the peer review process at Yale Cancer Center.

Advertisement

Latest Updated Articles

  • Marianne J. Davies, NP, Discusses the Peer Review Process at Yale Cancer Center
    Marianne J. Davies, NP, Discusses the Peer Review Process at Yale Cancer Center

    Published: July 10th 2014 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

15,000 NYC Nurses Strike Highlights Impact on Oncology Care

2

When Are TKIs Too Aggressive for a Patient With Renal Cell Carcinoma?

3

Linking Patient Experience With Next Steps in Renal Cell Carcinoma

4

Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer?

5

JSKN003 Given FDA Breakthrough Therapy Status in HER2+ PROC

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us